Comparison of creatinine- and cystatin C–based definitions of acute kidney injury in neonates with congenital diaphragmatic hernia

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background

Acute kidney injury (AKI) is a frequent complication in critically ill neonates and is associated with adverse outcomes. Infants with congenital diaphragmatic hernia (CDH) are particularly vulnerable due to pulmonary hypoplasia, hemodynamic instability, and exposure to nephrotoxic agents.

Methods

We retrospectively analyzed 193 neonates with CDH treated at a tertiary referral center (2012–2021). AKI was graded using modified pediatric RIFLE (pRIFLE), neonatal KDIGO (nKDIGO), and CysC-based neonatal AKI (CyNA) criteria, disregarding the urine output criteria. Clinical variables included CDH severity, extracorporeal membrane oxygenation (ECMO) use, and sepsis. Associations with AKI were examined using multivariable logistic regression.

Results

AKI incidence varied significantly by definition (CyNA 82% > pRIFLE 78% > nKDIGO 56%; CyNA vs. pRIFLE/nKDIGO p  = 0.028/ p  = 0.010). Moderate AKI was detected in 61% (CyNA), 38% (pRIFLE), and 26% (nKDIGO) of the cases. Severe AKI was detected in 42% (pRIFLE), 30% (nKDIGO), and 20% (CyNA) of the cases. Severe CyNA was significantly associated with in-hospital mortality ( p  = 0.003). The severity of AKI was associated with a stepwise increase in mortality (mild/moderate vs. severe, p  < 0.01), as well as prolonged hospitalization, kidney replacement therapy, and hypertension at discharge. Independent risk factors for AKI included lower observed-to-expected lung-to-head ratio, sepsis, and ECMO.

Conclusions

AKI is a frequent and clinically important complication in neonates with CDH and is strongly associated with overall disease severity, incidence of sepsis, and ECMO. Neonates with severe AKI have a higher mortality. CysC might serve as an additional biomarker for the detection of neonates with CDH and fatal outcome. Future studies should assess whether integrating both serum creatinine and CysC into AKI monitoring improves the early detection of neonates with CDH at risk of acute and chronic kidney disease.

A higher resolution version of the Graphical abstract is available as Supplementary information.

Article activity feed